Report

Exploring the Impact of the 21st Century Cures Act

EO

Emily Ortman

Formerly Milken Institute
AM

Amy Miller

Formerly Milken Institute
BH

Brenda Huneycutt

Formerly Milken Institute
AD

Anna Degarmo

Formerly Milken Institute
Smiling light-skinned, female-presenting individual with short blonde hair wearing a blue shirt on an outdoor backdrop

Sarah Wells Kocsis

Director, Public Health, Milken Institute Health
Sarah Wells Kocsis is a director on the public health team at Milken Institute Health, where she leads a portfolio of work focused on prevention, chronic disease, infrastructure, and other timely issues that are critical to advancing the role of public health in supporting healthy and productive communities.
TC

Tanisha Carino

Formerly Milken Institute
Topics
Philanthropy
Medical Philanthropy
Medical Research Funding
Health
Medical Research and Innovation
Clinical Trials
Medical Treatments and Therapies
Log in or create a free account to download
Full Report

FasterCures, a Center of the Milken Institute, and Society of Women’s Health Research (SWHR) advocated for the 21st Century Cures Act, which resulted in positive changes for women’s health research. The Cures Act, signed into law on December 13, 2016, aims to advance biomedical innovation, support research, and modernize medical product development to get treatments to patients more quickly.
 
In this brief report, FasterCures and SWHR explore how the Cures Act has affected the landscape for women in clinical research and understanding of sex- and gender-based differences in disease.

Log in or create a free account to download
Full Report

Related Content